(Press-News.org)
VIDEO:
The Natural Killer white blood cell in red is drawn to the cancerous B cell which has been treated with rituximab. It latches on to the side of the cell...
Click here for more information.
Scientists from the Manchester Collaborative Centre for Inflammation Research (MCCIR) have discovered why a particular cancer drug is so effective at killing cells. Their findings could be used to aid the design of future cancer treatments.
Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B cells. It is widely used in the treatment of B cell malignancies, such as lymphoma and leukaemia - as well as in autoimmune diseases like rheumatoid arthritis.
Using high-powered laser-based microscopes, researchers made videos of the process by which rituximab binds to a diseased cell and then attracts white blood cells known as natural killer (NK) cells to attack. They discovered that rituximab tended to stick to one side of the cancer cell, forming a cap and drawing a number of proteins over to that side. It effectively created a front and back to the cell - with a cluster of protein molecules massed on one side.
But what surprised the scientists most was how this changed the effectiveness of natural killer cells in destroying these diseased cells. When the NK cell latched onto the rituximab cap on the B cell, it had an 80% success rate at killing the cell. In contrast, when the B cell lacked this cluster of proteins on one side, it was killed only 40% of the time.
Professor Davis says: "These results were really unexpected. It was only possible for us to unravel the mystery of why this drug was so effective, through the use of video microscopy. By watching what happened within the cells we could clearly identify just why rituximab is such an effective drug – because it tended to reorganise the cancerous cell and make it especially prone to being killed."
He continues: "What our findings demonstrate is that this ability to polarise a cell by moving proteins within it should be taken into consideration when new antibodies are being tested as potential treatments for cancer cells. It appears that they can be up to twice as effective if they bind to a cell and reorganise it."
The findings from this study have been published online today on the website of the journal Blood. The research was carried out in collaboration with MedImmune, the global biologics research and development arm of AstraZeneca.
Commenting on the research Dr Matt Sleeman, Senior Director of Biology at MedImmune said: "Not only is this a great observation that can influence how we as a biotech company identify and design future therapies, it also shows the innovative 'out of the box' thinking that can be achieved by working in close partnership with academics at the top of their field. This unique partnership, bringing together industry and academia, demonstrates a real catalyst of scientific change within the UK, and I am excited by the potential of the MCCIR to bring further innovation that could ultimately bring benefit to patients."
Much of the research for this study was carried out during Professor Davis' time at Imperial College London. He will be continuing to use high quality video imaging at a microscopic level to investigate immunology at the MCCIR.
INFORMATION:
Professor Davis and MedImmune would like to acknowledge the funding they received from the Medical Research Council which helped make this study possible. The aim of the grant was to bring industry and academia closer together.
Video reveals cancer cells' Achilles' heel
2013-04-24
ELSE PRESS RELEASES FROM THIS DATE:
Important fertility mechanism discovered
2013-04-24
Scientists in Mainz and Aachen have discovered a new mechanism that controls egg cell fertility and that might have future therapeutic potential. It was revealed by Professor Dr. Walter Stöcker of the Institute of Zoology at Johannes Gutenberg University Mainz (JGU) that the blood protein fetuin-B plays an important and previously unknown role in the fertilization of oocytes. Fetuin-B, first identified in the year 2000, is formed in the liver and secreted into the blood stream. During a joint research project with researchers at RWTH Aachen University headed by Professor ...
Mild blast injury causes molecular changes in brain akin to Alzheimer, Pitt team says
2013-04-24
A multicenter study led by scientists at the University of Pittsburgh School of Medicine shows that mild traumatic brain injury after blast exposure produces inflammation, oxidative stress and gene activation patterns akin to disorders of memory processing such as Alzheimer's disease. Their findings were recently reported in the online version of the Journal of Neurotrauma.
Blast-induced traumatic brain injury (TBI) has become an important issue in combat casualty care, said senior investigator Patrick Kochanek, M.D., professor and vice chair of critical care medicine ...
New LED streetlight design curbs light pollution
2013-04-24
WASHINGTON, April 24, 2013—Streetlights illuminate the night, shining upon roadways and sidewalks across the world, but these ubiquitous elements of the urban environment are notoriously inefficient and major contributors to light pollution that washes out the night sky. Recent innovations in light emitting diodes (LEDs) have improved the energy efficiency of streetlights, but, until now, their glow still wastefully radiated beyond the intended area. A team of researchers from Taiwan and Mexico has developed a new lighting system design that harnesses high-efficiency LEDs ...
Recipe for low-cost, biomass-derived catalyst for hydrogen production
2013-04-24
UPTON, NY — In a paper to be published in an upcoming issue of Energy & Environmental Science (now available online), researchers at the U.S. Department of Energy's Brookhaven National Laboratory describe details of a low-cost, stable, effective catalyst that could replace costly platinum in the production of hydrogen. The catalyst, made from renewable soybeans and abundant molybdenum metal, produces hydrogen in an environmentally friendly, cost-effective manner, potentially increasing the use of this clean energy source.
The research has already garnered widespread recognition ...
International study finds new genetic links to juvenile arthritis
2013-04-24
CINCINNATI – Researchers report in Nature Genetics they have increased the number of confirmed genes linked to juvenile idiopathic arthritis (JIA) from three to 17 – a finding that will clarify how JIA fits into the spectrum of autoimmune disorders and help identify potential treatment targets.
Published April 21, the study involves an international research team that analyzed 2,816 JIA cases recruited from more than 40 pediatric rheumatology clinics. It was the largest collaborative patient population of JIA to date, including patient DNA samples from across the United ...
Research finds targeted screening for hepatitis C is cost-effective
2013-04-24
CINCINNATI—Researchers at the University of Cincinnati have found that targeted screening for populations with a higher estimated prevalence for hepatitis C may be cost-effective.
These findings, published in the April 24, 2013, online edition of the journal Clinical Infectious Diseases, indicate that targeted screening for chronic hepatitis C virus infection is cost-effective when the prevalence of hepatitis C in a population exceeds 0.84 percent (84/10,000).
The study further demonstrates how a screening tool, which can be incorporated into an electronic health ...
Sunlit snow triggers atmospheric cleaning, ozone depletion in the Arctic
2013-04-24
National Science Foundation-funded researchers at Purdue University have discovered that sunlit snow is the major source of atmospheric bromine in the Arctic, the key to unique chemical reactions that purge pollutants and destroy ozone.
The new research also indicates that the surface snowpack above Arctic sea ice plays a previously unappreciated role in the bromine cycle and that loss of sea ice, which been occurring at an increasingly rapid pace in recent years, could have extremely disruptive effects in the balance of atmospheric chemistry in high latitudes.
The ...
UNL team's discovery yields supertough, strong nanofibers
2013-04-24
University of Nebraska-Lincoln materials engineers have developed a structural nanofiber that is both strong and tough, a discovery that could transform everything from airplanes and bridges to body armor and bicycles.
Their findings are featured on the cover of this week's April issue of the American Chemical Society's journal, ACS Nano.
"Whatever is made of composites can benefit from our nanofibers," said the team's leader, Yuris Dzenis, McBroom Professor of Mechanical and Materials Engineering and a member of UNL's Nebraska Center for Materials and Nanoscience.
"Our ...
Guelph scientists develop first vaccine to help control autism symptoms
2013-04-24
A first-ever vaccine created by University of Guelph researchers for gut bacteria common in autistic children may also help control some autism symptoms.
The groundbreaking study by Brittany Pequegnat and Guelph chemistry professor Mario Monteiro appears this month in the journal Vaccine.
They developed a carbohydrate-based vaccine against the gut bug, Clostridium bolteae.
C. bolteae is known to play a role in gastrointestinal disorders, and it often shows up in higher numbers in the GI tracts of autistic children than in those of healthy kids.
More than 90 per ...
Deep, permeable soils buffer impacts of crop fertilizer on Amazon streams, MBL study finds
2013-04-24
WOODS HOLE, Mass.—The often damaging impacts of intensive agriculture on nearby streams, rivers, and their wildlife has been well documented in temperate zones, such as North America and Europe.
Yet a new study in an important tropical zone—the fast-changing southern Amazon, a region marked by widespread replacement of native forest by cattle ranches and more recently croplands—suggests that at least some of those damaging impacts may be buffered by the very deep and highly permeable soils that characterize large areas of the expanding cropland.
The study, led by Christopher ...